1-4 of 4
Marie France Demierre, MD
Close
Sort by
Journal Articles

Clinically Significant Responses Achieved with Romidepsin in 37 Patient with Cutaneous T-Cell Lymphoma (CTCL) with Blood Involvement.

Youn H Kim, MD, Marie-France Demierre, MD, Ellen J Kim, MD, Alain H Rook, MD, Adam Lerner, MD, Madeleine Duvic, MD, Sunil Reddy, MD, Tadeusz Robak, MD, PhD, Jürgen C Becker, MD, Alexey Samtsov, MD, William McCulloch, MB, FRCP, Sean Whittaker, MD, FRCP
Journal: Blood
Blood (2009) 114 (22): 2683.
https://doi.org/10.1182/blood.V114.22.2683.2683
Published: 2009
Journal Articles

Characterization of Cyclic Hematologic Changes Observed in Patients with Cutaneous T-Cell Lymphoma (CTCL) Receiving Romidepsin, a Novel Histone Deacetylase (HDAC) Inhibitor.

Sean Whittaker, MD, FRCP, Ellen J Kim, MD, Miles Prince, Marie France Demierre, MD, Cynthia Giver, Sagar Lonial, MD, Richard Piekarz, MD, PhD, Youn H Kim, MD, Jean Nichols, PhD, Darrell Nix, Ph.D., Susan Bates, MD
Journal: Blood
Blood (2009) 114 (22): 3701.
https://doi.org/10.1182/blood.V114.22.3701.3701
Published: 2009
Journal Articles

Multicenter Trial of Photopheresis in Early Stage Mycosis Fungoides

Madeleine Duvic, MD, Rakhshandra Talpur, MD, Elma D Baron, MD, Larisa J. Geskin, MD, Marie-France Demierre, MD, John Zic, MD, Kimberly Bohjanan, MD
Journal: Blood
Blood (2008) 112 (11): 4942.
https://doi.org/10.1182/blood.V112.11.4942.4942
Published: 2008
Journal Articles

Clinically Significant Responses Achieved with Romidepsin in Treatment-Refractory Cutaneous T-Cell Lymphoma: Final Results from a Phase 2B, International, Multicenter, Registration Study

Youn Kim, MD, Sean Whittaker, MD, FRCP, Marie France Demierre, MD, Alain H Rook, MD, Adam Lerner, MD, Madeleine Duvic, MD, Sunil Reddy, MD, Ellen J Kim, MD, Tadeusz Robak, MD, Jürgen C Becker, MD, Alexey Samtsov, MD, William McCulloch, MB, FRCP, Archibald G Prentice, MBChB, FRCP, FRCPath
Journal: Blood
Blood (2008) 112 (11): 263.
https://doi.org/10.1182/blood.V112.11.263.263
Published: 2008